EdgarLookup

CARVANA CO. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CARVANA CO. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
6.9%
Profit Margin
Net income ÷ revenue
10.7%
Return on Assets
Net income ÷ assets
2.61x
Debt-to-Equity
Total liabilities ÷ equity
+48.6%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $20.32B Feb 18, 2026
FY2025 Dec 31, 2024 $13.67B Feb 18, 2026
FY2025 Dec 31, 2023 $10.77B Feb 18, 2026
FY2024 Dec 31, 2022 $13.60B Feb 19, 2025
FY2023 Dec 31, 2021 $12.81B Feb 22, 2024
FY2020 Dec 31, 2020 $1.83B Feb 25, 2021
FY2020 Sep 30, 2020 $1.54B Feb 25, 2021
FY2020 Jun 30, 2020 $1.12B Feb 25, 2021
FY2020 Mar 31, 2020 $1.10B Feb 25, 2021
FY2020 Dec 31, 2019 $1.10B Feb 25, 2021

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $584.84M Feb 27, 2019
FY2018 Sep 30, 2018 $534.92M Feb 27, 2019
FY2018 Jun 30, 2018 $475.29M Feb 27, 2019
FY2018 Mar 31, 2018 $360.42M Feb 27, 2019
FY2018 Dec 31, 2017 $265.05M Feb 27, 2019
FY2018 Sep 30, 2017 $225.38M Feb 27, 2019
FY2018 Jun 30, 2017 $209.37M Feb 27, 2019
FY2018 Mar 31, 2017 $159.07M Feb 27, 2019
FY2017 Dec 31, 2016 $106.83M Mar 6, 2018
FY2017 Sep 30, 2016 $98.84M Mar 6, 2018

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.19B Feb 18, 2026
FY2025 Dec 31, 2024 $2.88B Feb 18, 2026
FY2025 Dec 31, 2023 $1.72B Feb 18, 2026
FY2024 Dec 31, 2022 $1.25B Feb 19, 2025
FY2023 Dec 31, 2021 $1.93B Feb 22, 2024
FY2020 Dec 31, 2020 $243.86M Feb 25, 2021
FY2020 Sep 30, 2020 $261.27M Feb 25, 2021
FY2020 Jun 30, 2020 $150.21M Feb 25, 2021
FY2020 Mar 31, 2020 $138.42M Feb 25, 2021
FY2020 Dec 31, 2019 $142.55M Feb 25, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.41B Feb 18, 2026
FY2025 Dec 31, 2024 $210.00M Feb 18, 2026
FY2025 Dec 31, 2023 $450.00M Feb 18, 2026
FY2024 Dec 31, 2022 ($1.59B) Feb 19, 2025
FY2023 Dec 31, 2021 ($135.00M) Feb 22, 2024
FY2020 Dec 31, 2020 ($63.34M) Feb 25, 2021
FY2020 Sep 30, 2020 ($7.09M) Feb 25, 2021
FY2020 Jun 30, 2020 ($40.83M) Feb 25, 2021
FY2020 Mar 31, 2020 ($59.89M) Feb 25, 2021
FY2020 Dec 31, 2019 ($41.13M) Feb 25, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.88B Feb 18, 2026
FY2025 Dec 31, 2024 $990.00M Feb 18, 2026
FY2025 Dec 31, 2023 ($80.00M) Feb 18, 2026
FY2024 Dec 31, 2022 ($2.35B) Feb 19, 2025

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.31B Feb 18, 2026
FY2025 Dec 31, 2024 $1.87B Feb 18, 2026
FY2025 Dec 31, 2023 $1.80B Feb 18, 2026
FY2024 Dec 31, 2022 $2.74B Feb 19, 2025
FY2023 Dec 31, 2021 $2.03B Feb 22, 2024
FY2022 Dec 31, 2020 $1.13B Feb 23, 2023
FY2021 Dec 31, 2019 $787.00M Feb 24, 2022
FY2020 Dec 31, 2018 $425.26M Feb 25, 2021
FY2019 Dec 31, 2017 $223.40M Feb 26, 2020
FY2018 Dec 31, 2016 $108.68M Feb 27, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.04B Feb 18, 2026
FY2025 Dec 31, 2024 $918.00M Feb 18, 2026
FY2025 Dec 31, 2023 $803.00M Feb 18, 2026
FY2024 Dec 31, 2022 ($1.32B) Feb 19, 2025
FY2023 Dec 31, 2021 ($2.59B) Feb 22, 2024
FY2022 Dec 31, 2020 ($608.00M) Feb 23, 2023
FY2021 Dec 31, 2019 ($757.00M) Feb 24, 2022
FY2020 Dec 31, 2018 ($414.34M) Feb 25, 2021
FY2019 Dec 31, 2017 ($199.92M) Feb 26, 2020
FY2018 Dec 31, 2016 ($240.23M) Feb 27, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $147.00M Feb 18, 2026
FY2025 Dec 31, 2024 $91.00M Feb 18, 2026
FY2025 Dec 31, 2023 $87.00M Feb 18, 2026
FY2024 Dec 31, 2022 $512.00M Feb 19, 2025
FY2023 Dec 31, 2021 $557.00M Feb 22, 2024
FY2022 Dec 31, 2020 $360.00M Feb 23, 2023
FY2021 Dec 31, 2019 $231.00M Feb 24, 2022
FY2020 Dec 31, 2018 $143.67M Feb 25, 2021
FY2019 Dec 31, 2017 $78.49M Feb 26, 2020
FY2018 Dec 31, 2016 $39.54M Feb 27, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.20B Feb 18, 2026
FY2025 Dec 31, 2024 $8.48B Feb 18, 2026
FY2024 Dec 31, 2023 $7.07B Feb 19, 2025
FY2023 Dec 31, 2022 $8.70B Feb 22, 2024
FY2022 Dec 31, 2021 $7.02B Feb 23, 2023
FY2021 Dec 31, 2020 $3.04B Feb 24, 2022
FY2020 Dec 31, 2019 $2.06B Feb 25, 2021
FY2019 Dec 31, 2018 $991.01M Feb 26, 2020
FY2018 Dec 31, 2017 $641.14M Feb 27, 2019
FY2017 Dec 31, 2016 $335.83M Mar 6, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.00B Feb 18, 2026
FY2025 Dec 31, 2024 $7.11B Feb 18, 2026
FY2024 Dec 31, 2023 $7.46B Feb 19, 2025
FY2023 Dec 31, 2022 $9.75B Feb 22, 2024
FY2022 Dec 31, 2021 $6.49B Feb 23, 2023
FY2021 Dec 31, 2020 $2.23B Feb 24, 2022
FY2020 Dec 31, 2019 $1.87B Feb 25, 2021
FY2019 Dec 31, 2018 $763.59M Feb 26, 2020
FY2018 Dec 31, 2017 $361.59M Feb 27, 2019
FY2017 Dec 31, 2016 $200.82M Mar 6, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.44B Feb 18, 2026
FY2025 Dec 31, 2024 $1.26B Feb 18, 2026
FY2024 Dec 31, 2023 $243.00M Feb 19, 2025
FY2023 Dec 31, 2022 ($518.00M) Feb 22, 2024
FY2022 Dec 31, 2021 $306.00M Feb 23, 2023
FY2021 Dec 31, 2020 $388.00M Feb 24, 2022
FY2020 Dec 31, 2019 $98.11M Feb 25, 2021
FY2019 Dec 31, 2018 $79.69M Feb 26, 2020
FY2018 Dec 31, 2017 $125.74M Feb 27, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.00M Feb 18, 2026
FY2025 Dec 31, 2024 $0 Feb 18, 2026
FY2022 Dec 31, 2022 $0 Feb 23, 2023
FY2022 Dec 31, 2021 $9.00M Feb 23, 2023
FY2022 Dec 31, 2020 $9.00M Feb 23, 2023
FY2020 Dec 31, 2019 $9.35M Feb 25, 2021
FY2019 Dec 31, 2018 $9.35M Feb 26, 2020
FY2018 Dec 31, 2017 $0 Feb 27, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($9.00M) Feb 18, 2026
FY2025 Dec 31, 2024 ($1.42B) Feb 18, 2026
FY2024 Dec 31, 2023 ($1.63B) Feb 19, 2025
FY2023 Dec 31, 2022 ($2.08B) Feb 22, 2024
FY2022 Dec 31, 2021 ($489.00M) Feb 23, 2023
FY2021 Dec 31, 2020 ($354.00M) Feb 24, 2022
FY2020 Dec 31, 2019 ($183.03M) Feb 25, 2021
FY2019 Dec 31, 2018 ($68.38M) Feb 26, 2020
FY2018 Dec 31, 2017 ($12.90M) Feb 27, 2019

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.33B Feb 18, 2026
FY2025 Dec 31, 2024 $1.72B Feb 18, 2026
FY2025 Dec 31, 2023 $530.00M Feb 18, 2026
FY2024 Dec 31, 2022 $434.00M Feb 19, 2025
FY2023 Dec 31, 2021 $403.00M Feb 22, 2024
FY2022 Dec 31, 2020 $301.00M Feb 23, 2023
FY2021 Dec 31, 2019 $76.00M Feb 24, 2022
FY2020 Dec 31, 2018 $78.86M Feb 25, 2021
FY2019 Dec 31, 2017 $172.68M Feb 26, 2020
FY2018 Dec 31, 2016 $39.18M Feb 27, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.92B Feb 18, 2026
FY2024 Dec 31, 2024 $5.30B Feb 19, 2025
FY2023 Dec 31, 2023 $5.18B Feb 22, 2024
FY2022 Dec 31, 2022 $6.48B Feb 23, 2023
FY2021 Dec 31, 2021 $2.74B Feb 24, 2022
FY2020 Dec 31, 2020 $1.21B Feb 25, 2021
FY2019 Dec 31, 2019 $716.74M Feb 26, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 10 Feb 18, 2026
FY2025 Dec 31, 2024 1 Feb 18, 2026
FY2025 Dec 31, 2023 4 Feb 18, 2026
FY2024 Dec 31, 2022 (15) Feb 19, 2025
FY2023 Dec 31, 2021 (1) Feb 22, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 8 Feb 18, 2026
FY2025 Dec 31, 2024 1 Feb 18, 2026
FY2025 Dec 31, 2023 0 Feb 18, 2026
FY2024 Dec 31, 2022 (15) Feb 19, 2025
FY2023 Dec 31, 2021 (1) Feb 22, 2024
FY2022 Dec 31, 2020 (2) Feb 23, 2023
FY2021 Dec 31, 2019 (2) Feb 24, 2022